Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease.

Belarif L, Danger R, Kermarrec L, Nerrière-Daguin V, Pengam S, Durand T, Mary C, Kerdreux E, Gauttier V, Kucik A, Thepenier V, Martin JC, Chang C, Rahman A, Guen NS, Braudeau C, Abidi A, David G, Malard F, Takoudju C, Martinet B, Gérard N, Neveu I, Neunlist M, Coron E, MacDonald TT, Desreumaux P, Mai HL, Le Bas-Bernardet S, Mosnier JF, Merad M, Josien R, Brouard S, Soulillou JP, Blancho G, Bourreille A, Naveilhan P, Vanhove B, Poirier N.

J Clin Invest. 2019 Apr 2;130:1910-1925. doi: 10.1172/JCI121668. eCollection 2019 Apr 2.

2.

HLA-DR expression in neonates after cardiac surgery under cardiopulmonary bypass: a pilot study.

Chenouard A, Braudeau C, Cottron N, Bourgoin P, Salabert N, Roquilly A, Josien R, Joram N, Asehnoune K.

Intensive Care Med Exp. 2018 Jan 11;6(1):1. doi: 10.1186/s40635-017-0166-x.

3.

A standardized flow cytometry procedure for the monitoring of regulatory T cells in clinical trials.

Pitoiset F, Barbié M, Monneret G, Braudeau C, Pochard P, Pellegrin I, Trauet J, Labalette M, Klatzmann D, Rosenzwajg M.

Cytometry B Clin Cytom. 2018 Sep;94(5):621-626. doi: 10.1002/cyto.b.21622. Epub 2018 Jan 23.

PMID:
29316248
4.

Cell-surface C-type lectin-like receptor CLEC-1 dampens dendritic cell activation and downstream Th17 responses.

Lopez Robles MD, Pallier A, Huchet V, Le Texier L, Remy S, Braudeau C, Delbos L, Moreau A, Louvet C, Brosseau C, Royer PJ, Magnan A, Halary F, Josien R, Cuturi MC, Anegon I, Chiffoleau E.

Blood Adv. 2017 Mar 22;1(9):557-568. doi: 10.1182/bloodadvances.2016002360. eCollection 2017 Mar 28.

5.

Thymic stromal lymphopoietin does not activate human basophils.

Salabert-Le Guen N, Hémont C, Delbove A, Poli C, Braudeau C, Fantou A, Amouriaux K, Bériou G, Martin JC, Colas L, Soumelis V, Josien R.

J Allergy Clin Immunol. 2018 Apr;141(4):1476-1479.e6. doi: 10.1016/j.jaci.2017.11.012. Epub 2017 Dec 5. No abstract available.

PMID:
29208546
6.

Standardized whole blood stimulation improves immunomonitoring of induced immune responses in multi-center study.

Duffy D, Rouilly V, Braudeau C, Corbière V, Djebali R, Ungeheuer MN, Josien R, LaBrie ST, Lantz O, Louis D, Martinez-Caceres E, Mascart F, Ruiz de Morales JG, Ottone C, Redjah L, Guen NS, Savenay A, Schmolz M, Toubert A, Albert ML; Multinational FOCIS Centers of Excellence.

Clin Immunol. 2017 Oct;183:325-335. doi: 10.1016/j.clim.2017.09.019. Epub 2017 Sep 22.

PMID:
28943400
7.

Dysregulated Responsiveness of Circulating Dendritic Cells to Toll-Like Receptors in ANCA-Associated Vasculitis.

Braudeau C, Néel A, Amouriaux K, Martin JC, Rimbert M, Besançon A, Giraudet S, Terrien C, Aliaga M, Salabert-Le Guen N, Hémont C, Hamidou M, Josien R.

Front Immunol. 2017 Feb 9;8:102. doi: 10.3389/fimmu.2017.00102. eCollection 2017.

8.

First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28.

Poirier N, Blancho G, Hiance M, Mary C, Van Assche T, Lempoels J, Ramael S, Wang W, Thepenier V, Braudeau C, Salabert N, Josien R, Anderson I, Gourley I, Soulillou JP, Coquoz D, Vanhove B.

J Immunol. 2016 Dec 15;197(12):4593-4602. Epub 2016 Nov 14.

9.

Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis.

Braudeau C, Amouriaux K, Néel A, Herbreteau G, Salabert N, Rimbert M, Martin JC, Hémont C, Hamidou M, Josien R.

J Autoimmun. 2016 Jun;70:73-9. doi: 10.1016/j.jaut.2016.03.015. Epub 2016 Apr 18.

PMID:
27102145
10.

Receptor activating NF-κB ligand (RANKL) is a constitutive intracellular protein in resting human basophils and is strongly induced on their surface by interleukin 3.

Poli C, Martin JC, Braudeau C, Bériou G, Hémont C, Charrier C, Guérin S, Heslan M, Josien R.

Immunobiology. 2015 May;220(5):692-700. doi: 10.1016/j.imbio.2014.11.009. Epub 2014 Nov 21.

PMID:
25433635
11.

Involvement of the CX3CL1 (fractalkine)/CX3CR1 pathway in the pathogenesis of acute graft-versus-host disease.

Brissot E, Bossard C, Malard F, Braudeau C, Chevallier P, Guillaume T, Delaunay J, Josien R, Gregoire M, Gaugler B, Mohty M.

J Leukoc Biol. 2015 Feb;97(2):227-35. doi: 10.1189/jlb.5HI0714-325R. Epub 2014 Nov 24.

PMID:
25420917
12.

Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage.

Roquilly A, Broquet A, Jacqueline C, Masson D, Segain JP, Braudeau C, Vourc'h M, Caillon J, Altare F, Josien R, Retière C, Villadangos J, Asehnoune K.

Crit Care Med. 2014 Dec;42(12):e752-61. doi: 10.1097/CCM.0000000000000658.

PMID:
25289930
13.

Impaired blood dendritic cell numbers and functions after aneurysmal subarachnoid hemorrhage.

Roquilly A, Braudeau C, Cinotti R, Dumonte E, Motreul R, Josien R, Asehnoune K.

PLoS One. 2013 Aug 9;8(8):e71639. doi: 10.1371/journal.pone.0071639. eCollection 2013.

14.

Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease.

Braudeau C, Graveleau J, Rimbert M, Néel A, Hamidou M, Grosbois B, Besançon A, Giraudet S, Terrien C, Josien R, Masseau A.

Blood Cells Mol Dis. 2013 Apr;50(4):281-8. doi: 10.1016/j.bcmd.2013.01.001. Epub 2013 Jan 26.

PMID:
23357793
15.

Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness.

Hémont C, Neel A, Heslan M, Braudeau C, Josien R.

J Leukoc Biol. 2013 Apr;93(4):599-609. doi: 10.1189/jlb.0912452. Epub 2013 Jan 22.

PMID:
23341538
16.

Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis.

Rimbert M, Hamidou M, Braudeau C, Puéchal X, Teixeira L, Caillon H, Néel A, Audrain M, Guillevin L, Josien R.

PLoS One. 2011 Apr 8;6(4):e18734. doi: 10.1371/journal.pone.0018734.

17.

Analysis of the peripheral T-cell repertoire in kidney transplant patients.

Miqueu P, Degauque N, Guillet M, Giral M, Ruiz C, Pallier A, Braudeau C, Roussey-Kesler G, Ashton-Chess J, Doré JC, Thervet E, Legendre C, Hernandez-Fuentes MP, Warrens AN, Goldman M, Volk HD, Janssen U, Wood KJ, Lechler RI, Bertrand D, Sébille V, Soulillou JP, Brouard S.

Eur J Immunol. 2010 Nov;40(11):3280-90. doi: 10.1002/eji.201040301. Epub 2010 Oct 27.

18.

Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.

Pallier A, Hillion S, Danger R, Giral M, Racapé M, Degauque N, Dugast E, Ashton-Chess J, Pettré S, Lozano JJ, Bataille R, Devys A, Cesbron-Gautier A, Braudeau C, Larrose C, Soulillou JP, Brouard S.

Kidney Int. 2010 Sep;78(5):503-13. doi: 10.1038/ki.2010.162. Epub 2010 Jun 9.

19.

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.

Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S, Craciun L, Sergeant R, Brouard S, Rovis F, Jimenez E, Ballow A, Giral M, Rebollo-Mesa I, Le Moine A, Braudeau C, Hilton R, Gerstmayer B, Bourcier K, Sharif A, Krajewska M, Lord GM, Roberts I, Goldman M, Wood KJ, Newell K, Seyfert-Margolis V, Warrens AN, Janssen U, Volk HD, Soulillou JP, Hernandez-Fuentes MP, Lechler RI.

J Clin Invest. 2010 Jun;120(6):1848-61. doi: 10.1172/JCI39922. Epub 2010 May 24.

20.

Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response.

Kovalchin J, Krieger J, Genova M, Collins K, Augustyniak M, Masci A, Hittinger T, Kuca B, Edan G, Braudeau C, Rimbert M, Patel U, Mascioli E, Zanelli E.

J Neuroimmunol. 2010 Aug 25;225(1-2):153-63. doi: 10.1016/j.jneuroim.2010.04.008. Epub 2010 May 13.

PMID:
20466440
21.

Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis.

Michel L, Berthelot L, Pettré S, Wiertlewski S, Lefrère F, Braudeau C, Brouard S, Soulillou JP, Laplaud DA.

J Clin Invest. 2008 Oct;118(10):3411-9. doi: 10.1172/JCI35365.

22.

Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.

Braudeau C, Ashton-Chess J, Giral M, Dugast E, Louis S, Pallier A, Braud C, Moreau A, Renaudin K, Soulillou JP, Brouard S.

Transplantation. 2008 Jul 15;86(1):130-6. doi: 10.1097/TP.0b013e31817b8dc5.

PMID:
18622290
23.

Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.

Berthelot L, Laplaud DA, Pettré S, Ballet C, Michel L, Hillion S, Braudeau C, Connan F, Lefrère F, Wiertlewski S, Guillet JG, Brouard S, Choppin J, Soulillou JP.

Eur J Immunol. 2008 Jul;38(7):1889-99. doi: 10.1002/eji.200838023.

24.

Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection.

Ashton-Chess J, Giral M, Mengel M, Renaudin K, Foucher Y, Gwinner W, Braud C, Dugast E, Quillard T, Thebault P, Chiffoleau E, Braudeau C, Charreau B, Soulillou JP, Brouard S.

J Am Soc Nephrol. 2008 Jun;19(6):1116-27. doi: 10.1681/ASN.2007101056. Epub 2008 Mar 27.

25.

Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis.

Braud C, Baeten D, Giral M, Pallier A, Ashton-Chess J, Braudeau C, Chevalier C, Lebars A, Léger J, Moreau A, Pechkova E, Nicolini C, Soulillou JP, Brouard S.

J Cell Biochem. 2008 Apr 15;103(6):1681-92.

PMID:
17910029
26.

Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance.

Brouard S, Mansfield E, Braud C, Li L, Giral M, Hsieh SC, Baeten D, Zhang M, Ashton-Chess J, Braudeau C, Hsieh F, Dupont A, Pallier A, Moreau A, Louis S, Ruiz C, Salvatierra O, Soulillou JP, Sarwal M.

Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15448-53. Epub 2007 Sep 14.

27.

Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome.

Braudeau C, Racape M, Giral M, Louis S, Moreau A, Berthelot L, Heslan M, Ashton-Chess J, Soulillou JP, Brouard S.

Transpl Int. 2007 Oct;20(10):845-55.

28.

Development of CD25- regulatory T cells following heart transplantation: evidence for transfer of long-term survival.

Degauque N, Lair D, Braudeau C, Haspot F, Sébille F, Dupont A, Merieau E, Brouard S, Soulillou JP.

Eur J Immunol. 2007 Jan;37(1):147-56.

29.

Serial evolution of TCR beta chain transcript mobilization in HIV type-1-infected patients following vaccine immune stimulation and HAART interruption.

Guille M, Andrieu M, Braudeau C, Ruiz C, Daniel N, Pallier A, Charmeteau B, Veziers J, Oden N, Bonilla N, Brouard S, Guillet JG, Soulillou JP.

AIDS Res Hum Retroviruses. 2006 Jul;22(7):648-56.

PMID:
16831089
30.

Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.

Louis S, Braudeau C, Giral M, Dupont A, Moizant F, Robillard N, Moreau A, Soulillou JP, Brouard S.

Transplantation. 2006 Feb 15;81(3):398-407.

PMID:
16477227
31.

Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.

Baeten D, Louis S, Braud C, Braudeau C, Ballet C, Moizant F, Pallier A, Giral M, Brouard S, Soulillou JP.

J Am Soc Nephrol. 2006 Jan;17(1):294-304. Epub 2005 Dec 7.

32.

Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation.

Brouard S, Dupont A, Giral M, Louis S, Lair D, Braudeau C, Degauque N, Moizant F, Pallier A, Ruiz C, Guillet M, Laplaud D, Soulillou JP.

Am J Transplant. 2005 Feb;5(2):330-40.

33.

Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer.

Braudeau C, Bouchet D, Tesson L, Iyer S, Rémy S, Buelow R, Anegon I, Chauveau C.

Gene Ther. 2004 Apr;11(8):701-10.

PMID:
14973545
34.

Generation of heme oxygenase-1-transgenic rats.

Braudeau C, Bouchet D, Toquet C, Tesson L, Ménoret S, Iyer S, Laboisse C, Willis D, Jarry A, Buelow R, Anegon I, Chauveau C.

Exp Biol Med (Maywood). 2003 May;228(5):466-71.

PMID:
12709570
35.

Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig.

Guillot C, Ménoret S, Guillonneau C, Braudeau C, Castro MG, Lowenstein P, Anegon I.

Blood. 2003 Apr 15;101(8):3325-33. Epub 2002 Dec 19.

36.

Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection.

Chauveau C, Bouchet D, Roussel JC, Mathieu P, Braudeau C, Renaudin K, Tesson L, Soulillou JP, Iyer S, Buelow R, Anegon I.

Am J Transplant. 2002 Aug;2(7):581-92.

37.

Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer.

Bouche D, Chauveau C, Roussel JC, Mathieu P, Braudeau C, Tesson L, Soulillou JP, Iyer S, Buelow R, Anegon I.

Transpl Immunol. 2002 May;9(2-4):235-8.

PMID:
12180836
38.

lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.

Ménoret S, Aubert D, Tesson L, Braudeau C, Pichard V, Ferry N, Anegon I.

Hum Gene Ther. 2002 Jul 20;13(11):1383-90.

PMID:
12162820
39.

Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.

Guillot C, Guillonneau C, Mathieu P, Gerdes CA, Ménoret S, Braudeau C, Tesson L, Renaudin K, Castro MG, Löwenstein PR, Anegon I.

J Immunol. 2002 Feb 15;168(4):1600-9.

Supplemental Content

Loading ...
Support Center